Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-12

Clinical Trial Update: Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of Prolia (denosumab) in men with osteoporosis in Mainland China; the study is currently ACTIVE_NOT_RE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prolia (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING